Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Menon

Showing results (421-430 of 428) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 428 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimicMir Alikhan, Joo Y Song, Aliyah R Sohani, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Leukemia|November 8, 2024
Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDSPeng Li, F N U Alnoor, Wei Xie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Pageof 43

Showing results (421-430 of 428) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 428 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimicMir Alikhan, Joo Y Song, Aliyah R Sohani, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Leukemia|November 8, 2024
Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDSPeng Li, F N U Alnoor, Wei Xie, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Blood Cancer Journal|June 18, 2024
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsAmandeep Kaur, Alexandra E Rojek, Emily Symes, et al.
Pageof 43